Articles From: Astec Industries, Inc. Announces Its Third Quarter Conference Call October 21, 2014 at 10:00 a.m. Eastern Time to AstraZeneca Forecasts Annual Revenue of $45 Billion by 2023


CHATTANOOGA, Tenn., Sept.
Sign-up for Astec Industries, Inc. to Present at 2014 Invest-TN Equity Conference investment picks
CHATTANOOGA, Tenn., Sept.
Sign-up for Astec Industries, Inc. to Present at Credit Suisse 5th Annual Small & Mid Cap Conference investment picks
CHATTANOOGA, Tenn., Nov.
Sign-up for Astec Industries, Inc. to Present at Goldman Sachs Industrials Conference 2014 investment picks
CHATTANOOGA, Tenn., Nov.
Sign-up for Astec Industries, Inc. to Present at Robert W. Baird's 2014 Industrial Conference investment picks
Asterias Biotherapeutics, Inc. (OTCBB: ASTY) announced today that on October 1, 2014 the company will distribute 8,000,000 warrants to purchase common shares of BioTime, Inc. (the “BioTime Warrants”) at a purchase price of $5.00 per common share to holders of record on September 15, 2014 of its Series A common stock.
Sign-up for Asterias Biotherapeutics Announces Distribution Date of BioTime Warrants and Conversion Date of Series B Common Stock into Series A Common Stock investment picks
Provides for Immediate Release of Initial Grant Funds MENLO PARK, Calif.
Sign-up for Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury investment picks
2014/11/10
MENLO PARK, Calif.
Sign-up for Asterias Biotherapeutics Reports Third Quarter Financial and Operating Results investment picks
Trading on NYSE MKT Expected to Begin on October 8, 2014 under Ticker Symbol AST MENLO PARK, Calif.
Sign-up for Asterias Biotherapeutics to List its Series A Common Stock on NYSE MKT investment picks
2014/10/31
MENLO PARK, Calif.
Sign-up for Asterias Biotherapeutics to Report Third Quarter Results on November 10, 2014 investment picks
Aston Hill Appoints New Member to its Board of Directors Canada NewsWire CALGARY , Nov.
Sign-up for Aston Hill Appoints New Member to its Board of Directors investment picks
2014/11/27
Aston Hill Asset Management Inc. Refiles Interim Financial Reports for Mutual Funds Canada NewsWire TORONTO , Nov.
Sign-up for Aston Hill Asset Management Inc. Refiles Interim Financial Reports for Mutual Funds investment picks
2014/10/22
Aston Hill Capital Markets Inc. Declares Distributions Canada NewsWire TORONTO , Oct.
Sign-up for Aston Hill Capital Markets Inc. Declares Distributions investment picks
2014/9/19
Aston Hill Capital Markets Inc. declares distributions Canada NewsWire TORONTO , Sept.
Sign-up for Aston Hill Capital Markets Inc. declares distributions investment picks
2014/11/19
Aston Hill Capital Markets Inc. Declares Distributions Canada NewsWire TORONTO , Nov.
Sign-up for Aston Hill Capital Markets Inc. Declares Distributions investment picks
Aston Hotels & Resorts, an operating business of Interval Leisure Group (Nasdaq:IILG), announced that it has entered into property management agreements with Split Rock Resort & Golf Club and The Mountain Laurel Resort & Spa situated in the scenic Pocono Mountains region of Lake Harmony, Pennsylvania.
Sign-up for Aston Hotels & Resorts Assumes Management of Split Rock Resort & Golf Club and Mountain Laurel Resort & Spa investment picks
2014/10/7
LAKE SUCCESS, N.Y. , Oct.
Sign-up for Astoria Bank and Long Island Girl Scouts Distribute School Supplies to Local Children investment picks
2014/12/1
LAKE SUCCESS, N.Y. , Dec.
Sign-up for Astoria Bank Opens Branch In Melville Today investment picks
2014/10/9
LAKE SUCCESS, N.Y. , Oct.
Sign-up for Astoria Bank Unveils Plans For Melville Branch investment picks
2014/10/15
Quarterly Cash Dividend of $0.04 Per Common Share Declared LAKE SUCCESS, N.Y. , Oct.
Sign-up for Astoria Financial Corporation Reports Third Quarter Earnings Per Common Share Of $0.17 investment picks
2014/10/1
LAKE SUCCESS, N.Y. , Oct.
Sign-up for Astoria Financial Corporation Schedules Third Quarter 2014 Earnings Release & Conference Call investment picks
LONDON and SUNNYVALE, Calif.
Sign-up for AstraZeneca And Pharmacyclics Enter Clinical Trial Collaboration To Evaluate IMBRUVICA® In Hematologic Cancers investment picks
LONDON and SUNNYVALE, Calif.
Sign-up for AstraZeneca And Pharmacyclics Enter Immuno-Oncology Clinical Trial Collaboration With IMBRUVICA® In Solid Tumors investment picks
AstraZeneca (NYSE: AZN) today announced that it has begun a pre-clinical development program to evaluate the ability of investigational antibody, MEDI2452, to rapidly and specifically reverse the antiplatelet effects of ticagrelor in rare emergency situations such as urgent surgery, or in the event of major bleeding.
Sign-up for AstraZeneca Announces Initiation of Development Program for BRILINTA (ticagrelor) Reversal Agent investment picks
2014/11/21
AstraZeneca today announced plans to expand its biologics manufacturing center in Frederick, Md.
Sign-up for AstraZeneca Announces Plans to Expand its Frederick, Maryland Biologics Manufacturing Center investment picks
2014/11/18
By Alex MacDonald LONDON--
Sign-up for AstraZeneca Bets Long Term on Cancer Drugs -- 2nd Update investment picks
2014/11/18
By Alex MacDonald LONDON--U.K.-listed pharmaceutical company AstraZeneca PLC on Tuesday said its pipeline of drugs is expected to drive strong and consistent revenue growth, delivering annual revenues in excess of $45 billion by 2023.
Sign-up for AstraZeneca Forecasts Annual Revenue of $45 Billion by 2023 investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Astec Industries, Inc. Announces Its Third Quarter Conference Call October 21, 2014 at 10:00 a.m. Eastern Time to AstraZeneca Forecasts Annual Revenue of $45 Billion by 2023
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent